CD44 and neoplasm: Thus, the contribution of CD44 to the development of the tumor process, through the above mechanisms, has been described for brain cancer, head and neck cancer, breast cancer, kidney cancer, liver cancer, pancreatic cancer, gallbladder cancer, esophageal cancer, prostate cancer, gastrointestinal cancer, melanoma, squamous cell carcinoma, and sarcoma.